Jennifer Doering
Overview
Explore the profile of Jennifer Doering including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hickey J, Sharma N, Fairlamb M, Doering J, Adewunmi Y, Prieto K, et al.
Hum Vaccin Immunother
. 2025 Feb;
21(1):2460749.
PMID: 39903060
Circumsporozite protein (CSP), the most abundant surface protein in parasitic (Pf) sporozoite and an attractive target for malaria vaccine design, has been shown to induce protective humoral response in humans....
2.
Kumar P, Holland D, Secrist K, Taskar P, Dotson B, Saleh-Birdjandi S, et al.
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932338
Introducing new recombinant protein antigens to existing pediatric combination vaccines is important in improving coverage and affordability, especially in low- and middle-income countries (LMICs). This case-study highlights the analytical and...
3.
Peters C, Doering J
J Prof Nurs
. 2024 May;
52:86-93.
PMID: 38777531
Background: Background checks are used in nursing education to assess public risk. To date, no study has described the most common and most serious findings in nursing students. Purpose: Our...
4.
5.
Miller D, Doering J
West J Nurs Res
. 2023 Nov;
46(1):26-35.
PMID: 37982345
Background: People with chronic illnesses may struggle to adapt psychologically to the illness experience and have feelings of identity loss, self-diminishment, and biographical disruption. This may limit people's ability to...
6.
Kumru O, Bajoria S, Kaur K, Hickey J, Van Slyke G, Doering J, et al.
Hum Vaccin Immunother
. 2023 Nov;
19(2):2264594.
PMID: 37932241
Second-generation COVID-19 vaccines with improved immunogenicity (e.g., breadth, duration) and availability (e.g., lower costs, refrigerator stable) are needed to enhance global coverage. In this work, we formulated a clinical-stage SARS-CoV-2...
7.
Bajoria S, Kumru O, Doering J, Berman K, Van Slyke G, Prigodich A, et al.
Vaccines (Basel)
. 2023 Jun;
11(6).
PMID: 37376419
Aluminum-salt vaccine adjuvants (alum) are commercially available as micron-sized particles with varying chemical composition and crystallinity. There are reports of enhanced adjuvanticity when the alum's particle size is reduced to...
8.
Roy C, Ehrbar D, Van Slyke G, Doering J, Didier P, Doyle-Meyers L, et al.
NPJ Vaccines
. 2022 Dec;
7(1):164.
PMID: 36526642
Inhalation of the biothreat agent, ricin toxin (RT), provokes a localized inflammatory response associated with pulmonary congestion, edema, neutrophil infiltration, and severe acute respiratory distress. The extreme toxicity of RT...
9.
Bajoria S, Kaur K, Kumru O, Van Slyke G, Doering J, Novak H, et al.
Hum Vaccin Immunother
. 2022 Jun;
18(5):2079346.
PMID: 35666264
Low-cost, refrigerator-stable COVID-19 vaccines will facilitate global access and improve vaccine coverage in low- and middle-income countries. To this end, subunit-based approaches targeting the receptor-binding domain (RBD) of SARS-CoV-2 Spike...
10.
Gralton K, Doering J, Ngui E, Pan A, Schiffman R
J Pediatr Nurs
. 2022 Mar;
64:102-110.
PMID: 35248955
Purpose: The purpose of this study was to examine the relationship between resiliency factors and family functioning in families of preterm infants (< 37 weeks gestation) from two different racial...